IP Library Granted Patent US 7,993,401
Granted Patent B2
US 7,993,401 · App. 12/035,018 · Granted Aug 9, 2011

Solid state deformation processing of crosslinked high molecular weight polymeric materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,993,401
App. No.
12/035,018
Granted
Aug 9, 2011
Kind
B2
Abstract

Solid-state deformation processing of crosslinked high molecular weight polymers such as UHMWPE, for example by extrusion below the melt transition, produces materials with a combination of high tensile strength and high oxidative stability. The materials are especially suitable for use as bearing components in artificial hip and other implants. Treated bulk materials are anisotropic, with enhanced strength oriented along the axial direction. The material is oxidatively stable even after four weeks of accelerated aging in a pressure vessel containing five atmospheres of oxygen (ASTM F2003). Because of its oxidative stability, the deformation processed material is a suitable candidate for air-permeable packaging and gas sterilization, which has thus far been reserved for remelted crosslinked UHMWPE.

Claims (24)

1. A medical implant comprising a bearing component made by machining a gamma-crosslinked UHMWPE, wherein the gamma-crosslinked UHMWPE is in the form of a cylinder characterized by an axial direction and a transverse direction orthogonal to the axial direction, wherein the axial direction corresponds to the longitudinal direction of the cylinder, wherein the tensile strength in the axial direction is at least 60 MPa and wherein the tensile strength in the axial direction is 20% or more greater than the tensile strength in the transverse direction, and wherein the bearing component has a free radical concentration greater than 0.06×10 15 spins/gram.

2. A medical implant according to claim 1 , wherein the tensile strength in the axial direction is 60-100 MPa.

3. A medical implant according to claim 1 , wherein the tensile strength in the axial direction is 60-90 MPa.

4. A medical implant according to claim 1 , wherein the tensile strength in the axial direction is 60-80 MPa.

5. A medical implant according to claim 1 , wherein the oxidation index of the bearing component shows no measurable increase on exposure to 5 atm oxygen at 70° C. for 2 days.

6. A medical implant according to claim 1 , wherein the oxidation index of the bearing component shows no measurable increase on exposure to 5 atm oxygen at 70° C. for 4 days.

7. A medical implant according to claim 1 , wherein the bearing component is an acetabular cup.

8. A medical implant according to claim 1 , wherein the bearing component is a tibial plateau.

9. A medical implant according to claim 1 , wherein the bearing component comprises UHMWPE having a concentration of free radicals greater than 0.06×10 15 spins/g and less than 3×10 15 spins/g, and stable to oxidation for 4 weeks in 5 atm oxygen at 70° C., as measured by an increase in the oxidation index of 0.1 or less.

10. A medical implant according to claim 1 , wherein the bulk material is in the form of a cylindrical rod with a diameter of from about 2 inches to about 4 inches.

11. A medical implant according to claim 1 , wherein the implant is an artificial hip joint.

12. A medical implant according to claim 1 , wherein the UHMWPE is crosslinked with a gamma-irradiation dose of from 0.1 to 10 Mrad.

13. A medical implant according to claim 1 , wherein the UHMWPE is crosslinked with a gamma-irradiation dose of from 0.1 to 5 Mrad.

14. A bearing component for an artificial joint machined from a crosslinked UHMWPE, wherein the crosslinked UHMWPE is in the form of a cylinder characterized by an axial direction and a transverse direction orthogonal to the axial direction, wherein the axial direction corresponds to the longitudinal axis of the cylinder wherein the tensile strength in the axial direction is at least 60 MPa and wherein the tensile strength in the axial direction is 20% or more greater than the tensile strength in the transverse direction, and wherein the bearing component in use has a load bearing axis substantially coincident with the axial direction of the cylinder, and wherein the bearing component has a free radical concentration greater than 0.06×10 15 spins/gram.

15. A bearing component according to claim 14 , wherein the tensile strength in the axial direction is 60 to 100 MPa.

16. A bearing component according to claim 14 , wherein the tensile strength in the axial direction is 60-90 MPa.

17. A bearing component according to claim 14 , wherein the tensile strength in the axial direction is 60-80 MPa.

18. A bearing component according to claim 14 , wherein the tensile strength in the axial direction is 60-70 MPa.

19. A bearing component according to claim 14 , wherein the bearing component has an oxidation index that shows no measurable increase on exposure to 5 atm oxygen at 70° C. for 2 days.

20. A bearing component according to claim 14 , wherein the bearing component has an oxidation index that shows no measurable increase on exposure to 5 atm oxygen at 70° C. for 4 days.

21. A bearing component according to claim 14 , wherein the bearing component is an acetabular cup.

22. A bearing component according to claim 14 , wherein the bearing component is a tibial plateau.

23. A medical implant according to claim 1 , wherein the gamma-crosslinked UHMWPE is in the form of a cylinder having a circular cross section perpendicular to the axial direction.

24. A bearing component according to claim 14 , wherein the crosslinked UHMWPE is in the form of a cylinder having a circular cross section perpendicular to the axial direction.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241 Recorded Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC.; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTR-OBIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
Reel/Frame 037155/0082 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: BIOMET MANUFACTURING CORPORATION
To: BIOMET MANUFACTURING, LLC
Reel/Frame 032128/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2013
From: SCHROEDER, DAVID W.; FREEDMAN, JORDAN H.; GUNTER, JAMES E.; SALYER, BRIAN D.; HAWKINS, H. GENE
To: BIOMET MANUFACTURING CORP.
Reel/Frame 031527/0036 →
SECURITY AGREEMENT Recorded Nov 12, 2009
From: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTRO-BIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 023505/0241 →